The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 7,601–7,700 of 31,469
Jiménez‐Maldonado, A., García‐Suárez, P. C., Rentería, I., Moncada‐Jiménez, J., & Plaisance, E. P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165820 · Cited by 57
Navaneethan, S. D., Kirwan, J. P., Remer, E. M., Schneider, E., Addeman, B. T., Arrigain, S., Horwitz, E., Fink, J. C., Lash, J. P., McKenzie, C. A., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.028 · Cited by 48
Ali, M. M., Naquiallah, D., Qureshi, M., Mirza, M. I., Hassan, C., Masrur, M. A., Bianco, F. M., Frederick, P., Cristoforo, G. P., Gangemi, A., et al. (2021) · Epigenetics · doi:10.1080/15592294.2021.1876285 · Cited by 50
Poon, E. T., Parco Ming-fai, S. I. U., Wongpipit, W., Gibala, M. J., & Wong, S. H. (2021) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2021.11.003 · Cited by 53
Gu, P., Cheng, M., Hui, X. H., Lü, B., Jiang, W., & Shi, Z. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000588 · Cited by 48
Plat, J., Jellema, A., Ramakers, J. D., & Mensink, R. P. (2007) · Journal of Nutrition · doi:10.1093/jn/137.12.2635 · Cited by 48
Derosa, G., D’Angelo, A., Ragonesi, P. D., et al. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01238.x · Cited by 48
Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome
González, F., Sia, C. L., Stanczyk, F. Z., Blair, H. E., & Krupa, M. E. (2012) · Endocrine · doi:10.1007/s12020-012-9728-6 · Cited by 48
Falutz, J. (2007) · Nature Clinical Practice Endocrinology &Metabolism · doi:10.1038/ncpendmet0587 · Cited by 50
Rauchenzauner, M., Haberlandt, E., Scholl‐Bürgi, S., Karall, D., Schoenherr, E., Tatarczyk, T., Engl, J., Laimer, M. W., Luef, G. J., & Ebenbichler, C. F. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.03.017 · Cited by 48
Evaluation of metabolic syndrome in adults of Talca city, Chile
Mujica, V., Elba Leiva, M., Icaza, G., Díaz, N. S., Arredondo, M., Moore‐Carrasco, R., Orrego, R., Vásquez, M., & Palomo, I. F. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-14 · Cited by 48
Chan, J. C. N., Tong, P. C. Y., Chow, C. C., So, W., Ng, M. C. Y., Ma, R. C. W., Osaki, R., Cockram, C. S., & Chan, J. C. N. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.497 · Cited by 48
Terada, S., Yamamoto, S., Sekine, S., & AOYAMA, T. (2011) · Nutrition · doi:10.1016/j.nut.2011.04.008 · Cited by 48
Post-Transplantation Diabetes Mellitus
Kaplan, N. M., Palmer, B. F., & Mora, P. F. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200502000-00006 · Cited by 46
Cognitive Patterns in Relation to Biomarkers of Cerebrovascular Disease and Vascular Risk Factors
Miralbell, J., Elena López-Cancio, M., López-Olóriz, J., Arenillas, J. F., Barrios, M., Soriano-Raya, J. J., Galán, A., Cáceres, C. M., Alzamora, M. T., Pera, G., et al. (2013) · Cerebrovascular Diseases · doi:10.1159/000352059 · Cited by 47
Amylin and Its Relation to Insulin and Lipids in Obese Children Before and After Weight Loss
Reinehr, T., de Sousa, G., Niklowitz, P., & Roth, C. L. (2007) · Obesity · doi:10.1038/oby.2007.239 · Cited by 50
Gunton, J. E., Hitchman, R., & McElduff, A. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01205.x · Cited by 48
Wong, L. Y. F., Leung, R., Ong, K. L., & Cheung, B. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002233 · Cited by 48
Six‐minute walk test before and after a weight reduction program in obese subjects
Ekman, M., Klintenberg, M., Björck, U., Norström, F., & Ridderstråle, M. (2013) · Obesity · doi:10.1002/oby.20046 · Cited by 48
Bovet, P., Faeh, D., Gabriel, A., & Tappy, L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.11.1236-b · Cited by 49
Tang, D., Zhou, X. H., Li, X., Жао, Л., & Liu, F. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.12.001 · Cited by 47
Simha, V., Agarwal, A. K., Aronin, P. A., Iannaccone, S. T., & Garg, A. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32457 · Cited by 48
Plasma long‐chain fatty acids and the degree of obesity in Italian children
Scaglioni, S., Verduci, E., Salvioni, M., Bruzzese, M. G., Radaelli, G., Zetterström, R. H., Riva, E., & Agostoni, C. V. (2006) · Acta Paediatrica · doi:10.1080/08035250600764834 · Cited by 49
Adrenal Incidentaloma—A Modern Disease with Old Complications
Angeli, A., & Terzolo, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021436 · Cited by 47
Glueck, C. J., Aregawi, D. G., Winiarska, M., Agioria, M., Luo, G., Sieve, L., & Wang, P. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.6.831 · Cited by 48
Çağlar, G. S., Öztaş, E., Karadağ, D., Pabuçcu, R., & Demırtaş, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.092 · Cited by 48
Hermsdorff, H. H. M., Zulet, M. Á., Puchau, B., Bressan, J., & Martínez, J. A. (2008) · Nutrition · doi:10.1016/j.nut.2008.09.015 · Cited by 47
Lo, J. C.-M., Zhao, X., Scuteri, A., Brockwell, S. E., & Sowers, M. R. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.07.009 · Cited by 48
Cesari, M., Pessina, A. C., Zanchetta, M., Toni, R. D., Avogaro, A., Pedon, L., Dorigatti, F., Maiolino, G., & Rossi, G. P. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01714.x · Cited by 48
Lok, A. S.-F., Everhart, J. E., Chung, R. T., Padmanabhan, L., Greenson, J. K., Shiffman, M. L., Everson, G. T., Lindsay, K. L., Bonkovsky, H. L., Bisceglie, A. M. D., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.11.002 · Cited by 48
Biomarkers of Dietary Energy Restriction in Women at Increased Risk of Breast Cancer
Ong, K. R., Sims, A. H., Harvie, M., Chapman, M., Dunn, W. B., Broadhurst, D., Goodacre, R., Wilson, M., Thomas, N. A., Clarke, R. B., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0008 · Cited by 49
Impaired Central Insulin Response in Aged Wistar Rats: Role of Adiposity
Frutos, M. G.-S., Fernández‐Agulló, T., Solís, A. J. D., Andrés, A., Arribas, C., Carrascosa, J. M., & Ros, M. (2007) · Endocrinology · doi:10.1210/en.2007-0543 · Cited by 48
Baye, T. M., Zhang, Y., Smith, E., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1647 · Cited by 48
Östgren, C. J., Lindblad, U., Ranstam, J., Melander, A., & Råstam, L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00661.x · Cited by 47
Reinehr, T., Kieß, W., & Andler, W. (2005) · Metabolism · doi:10.1016/j.metabol.2004.10.008 · Cited by 48
Acanthosis nigricans and insulin resistance in overweight children and adolescents
Kluczynik, C. E. N., Mariz, L. S., Souza, L. C. F., et al. (2012) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962012000400002 · Cited by 48
Wannamethee, S. G., Tchernova, J., Whincup, P. H., Lowe, G. D. O., Rumley, A., Brown, K. E., Cherry, L., & Sattar, N. A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803544 · Cited by 48
Eriksson, B., Löf, M., Olausson, H., et al. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991371 · Cited by 48
Hjelmesaeth, J. S., Åsberg, A., Müller, F., Hartmann, A., & Jenssen, T. G. (2005) · Current Diabetes Reviews · doi:10.2174/1573399052952604 · Cited by 50
Docherty, P. D. (2009) · The Open Medical Informatics Journal · doi:10.2174/1874431100903010065 · Cited by 50
Effects of lifestyle modification on adipocytokine levels in obese patients.
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., Conde, R., & Jl, P. C. (2008) · PubMed · Cited by 48
Czupryniak, L., Loba, J., Pawlowski, M., Nowak, D., & Białasiewicz, P. (2005) · SLEEP · doi:10.1093/sleep/28.5.601 · Cited by 48
Sparsø, T., Andersen, G., Albrechtsen, A., Jørgensen, T., Borch‐Johnsen, K., Sandbæk, A., Lauritzen, T., Wasson, J., Permutt, M. A., Gläser, B., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1064-2 · Cited by 48
Meigs, J. B., Dupuis, J., Herbert, A. G., Liu, C., Wilson, P. W. F., & Cupples, L. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1212 · Cited by 48
Osei, K., Gaillard, T. R., & Schuster, D. (2005) · Obesity Research · doi:10.1038/oby.2005.23 · Cited by 48
Kain, K., Catto, A. J., & Grant, P. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00958.x · Cited by 48
Serum leptin levels in post-hepatitis liver cirrhosis
Greco, A. V., Mingrone, G., Favuzzi, A. M. R., Capristo, E., Gniuli, D., Addolorato, G., Brunani, A., Cavagnin, F., & Gasbarrini, A. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80157-9 · Cited by 47
Vignesh, J., & Mohan, V. (2007) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.32217 · Cited by 47
Chien, K., Lee, Y., Sung, F., Hsu, H., Su, T., & Lin, R. S. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.6.838 · Cited by 47
Derosa, G., Cicero, A. F. G., D’Angelo, A., et al. (2005) · Hypertension Research · doi:10.1291/hypres.28.917 · Cited by 48
Hayakawa, T., Nagai, Y., Nohara, E., et al. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90067-7 · Cited by 48
Sarafidis, P. A., Lasaridis, A. N., NILSSON, P., et al. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.09.010 · Cited by 48
Interactive educational simulators in diabetes care
Lehmann, E. D. (1997) · Medical Informatics · doi:10.3109/14639239709089834 · Cited by 48
Andersen, E., Burton, N. W., & Anderssen, S. A. (2012) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-9-47 · Cited by 47
Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0857 · Cited by 47
Aerobic Exercise and Postprandial Lipemia in Men with the Metabolic Syndrome
MESTEK, M. L., PLAISANCE, E. P., RATCLIFF, L. A., TAYLOR, J. K., WEE, S.-O., & GRANDJEAN, P. W. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181822ebd · Cited by 47
Mario, F. M., Graff, S. K., & Spritzer, P. M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0570-1 · Cited by 47
Berezin, A. Е., Kremzer, A. A., Berezina, T. A., & Martovitskaya, Y. V. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.07.002 · Cited by 47
Bathula, R., Hughes, A. D., Panerai, R. B., Potter, J. F., Thom, S., Francis, D. P., Shore, A. C., Kooner, J. S., & Chaturvedi, N. (2010) · Diabetologia · doi:10.1007/s00125-010-1818-5 · Cited by 46
Sundholm, J. K. M., Litwin, L. C., Rönö, K., Koivusalo, S. B., Eriksson, J. G., & Sarkola, T. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.037 · Cited by 51
Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
Calkin, C., McClelland, C., Cairns, K., Kamintsky, L., & Friedman, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.636174 · Cited by 47
Guo, J., Wan, Z., Cui, G., Pan, A., & Liu, G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15444-7 · Cited by 47
Lin, S., Hu, H., Chao, H.-L., Ho, B., Chen, C., Chan, L., Lin, H., Sun, Y., Lin, Y.-Y., Chen, P., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.737441 · Cited by 47
Kang, H., You, H. J., Lee, G., Lee, S. H., Yoo, T., Choi, M., Joo, S. K., Park, J. H., Chang, M. S., Lee, D. H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2078612 · Cited by 47
Li, R., Mai, T., Zheng, S., & Zhang, Y. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06700-3 · Cited by 56
Lee, D., Park, J. E., Kim, S. Y., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00927-5 · Cited by 47
Ahmed, E., El-Derany, M. O., Anwar, A. M., Saied, E. M., & Magdeldin, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010210 · Cited by 47
Kipp, Z. A., Xu, M., Bates, E. A., Lee, W., Kern, P. A., & Hinds, T. D. (2023) · Antioxidants · doi:10.3390/antiox12010170 · Cited by 51
Xia, W., Cai, Y., Zhang, S., & Wu, S. (2023) · BMC Public Health · doi:10.1186/s12889-023-16813-2 · Cited by 47
Kupffer cell programming by maternal obesity triggers fatty liver disease
Huang, H., Balzer, N. R., Seep, L., Šplíchalová, I., Blank-Stein, N., Viola, M. F., Taveras, E. F., Acil, K., Fink, D., Petrovic, F., et al. (2025) · Nature · doi:10.1038/s41586-025-09190-w · Cited by 52
Patel, R. T., Shukla, A. P., Ahn, S. M., Moreira, M., & Rubino, F. (2013) · Obesity · doi:10.1002/oby.20441 · Cited by 46
Mykhalchyshyn, G., Kobyliak, N. M., & Bodnar, P. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0170-1 · Cited by 47
Kouyama, K., Miyake, K., Zenibayashi, M., Hirota, Y., Teranishi, T., Tamori, Y., Kanda, H., Sakaguchi, K., Ohara, T., & Kasuga, M. (2008) · PubMed · doi:10.24546/81000134 · Cited by 47
Prior, S. J., Ryan, A. S., Stevenson, T. G., & Goldberg, A. P. (2013) · Obesity · doi:10.1002/oby.20609 · Cited by 52
Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance.
Solá, E., Vayá, A., Simó, M., Hernández‐Mijares, A., Morillas, C., España, F., Estellés, A., & Corella, D. (2007) · PubMed · Cited by 47
Association between serum adropin levels and gestational diabetes mellitus; a case–control study
Beigi, A., Shirzad, N., Nikpour, F., Nasli‐Esfahani, E., Emamgholipour, S., & Bandarian, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1081681 · Cited by 47
Insulin resistance is associated with poorer verbal fluency performance in women
Ekblad, L. L., Rinne, J. O., Puukka, P. J., Laine, H. K., Ahtiluoto, S., Sulkava, R. O., Viitanen, M. H., & Jula, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3715-4 · Cited by 49
Bollinger, L. M., Powell, J. J. S., Houmard, J. A., Witczak, C. A., & Brault, J. J. (2015) · Obesity · doi:10.1002/oby.21081 · Cited by 51
The Effect of Bikram Yoga on Arterial Stiffness in Young and Older Adults
Hunter, S. D., Dhindsa, M., Cunningham, E. R., Tarumi, T., Alkatan, M., Nualnim, N., & Tanaka, H. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2012.0709 · Cited by 47
Thrush, A. B., Brindley, D. N., Chabowski, A., Heigenhauser, G. J. F., & Dyck, D. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2565 · Cited by 48
Association between Family History Risk Categories and Prevalence of Diabetes in Chinese Population
Zhang, J., Yang, Z., Xiao, J., Xing, X., Lu, J., Weng, J., Jia, W., Ji, L., Shan, Z., Liu, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117044 · Cited by 50
The Architecture of Risk for Type 2 Diabetes: Understanding Asia in the Context of Global Findings
Abdullah, N., Attia, J., Oldmeadow, C. J., Scott, R. J., & Holliday, E. G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/593982 · Cited by 47
Marantos, G., Daskalakis, M., Karkavitsas, N. S., Matalliotakis, I., Papadakis, J. A., & Melissas, J. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1165-9 · Cited by 47
Rhéaume, C., Arsenault, B. J., Dumas, M.-P., Përusse, L., Tremblay, A., Bouchard, C., Poirier, P., & Després, J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2432 · Cited by 47
Dullaart, R. P. F., Annema, W., de Boer, J. F., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.037 · Cited by 47
de Oliveira, B. F. A., Chacra, A. P. M., Frauches, T. S., Vallochi, A. L., & Hacon, S. D. S. (2014) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2014.976893 · Cited by 47
García‐Fuentes, E., Murri, M., Garrido‐Sánchez, L., García‐Serrano, S., García‐Almeida, J. M., Moreno‐Santos, I., Tinahones, F. J., & Macías‐González, M. (2009) · Obesity · doi:10.1038/oby.2009.314 · Cited by 47
ELIZONDO, A., Julia Araya, A., Rodrigo, R., Signorini, C., Sgherri, C., Comporti, M., Poníachik, J., & Videla, L. A. (2008) · Biological Research · doi:10.4067/s0716-97602008000100008 · Cited by 47
Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans
Merl, V., Peters, A., Oltmanns, K. M., Kern, W., Jan Born, A., Fehm, H., & Schultes, B. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802971 · Cited by 47
Dietary fatty acids and insulin secretion: a population-based study
Rojo‐Martínez, G., Esteva, I., de Adana, M. S. R., Garcia-Almeida, J., Tinahones, F. J., Cardona, F., Morcillo, S., García‐Escobar, E., García‐Fuentes, E., & Soriguer, F. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602437 · Cited by 47
Endothelial dysfunction in Turkish patients with non‐alcoholic fatty liver disease
Şentürk, Ö., Kocaman, O., Hülagü, S., Sahin, T., Aygün, C., Konduk, B. T., & Çelebi, A. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01481.x · Cited by 47
Abhari, F. R., Andarieh, M. G., Farokhfar, A., & Ahmady, S. (2014) · BioMed Research International · doi:10.1155/2014/140851 · Cited by 47
Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease
Kao, C. C., Hsu, J. W.-C., Bandi, V., Hanania, N. A., Kheradmand, F., & Jahoor, F. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00599.2011 · Cited by 47
Jin, X. K., Amitani, K., Zamami, Y., Takatori, S., Hobara, N., Kawamura, N., Hirata, T., Wada, A., Kitamura, Y., & Kawasaki, H. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.02.019 · Cited by 48
Insulin resistance and postprandial triglyceride levels in primary renal disease
CHARLESWORTH, J. A., Kriketos, A. D., Jones, J. E., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.028 · Cited by 47
Yu, W., Hu, C., Zhang, R., Wang, C., Qin, W., Lu, J., Jiang, F., Tang, S., Bao, Y., Xiang, K., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.351 · Cited by 47
Abdullah, A. R., Hasan, H. A., & Raigangar, V. L. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0045 · Cited by 47
Nelson, T. L., Biggs, M. L., Kizer, J. R., Cushman, M., Hokanson, J. E., Furberg, C. D., & Mukamal, K. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3026 · Cited by 47
Park, Y.-H., Shin, J., Han, J., Park, Y., & Yim, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125338 · Cited by 50
Olynyk, J. K., Knuiman, M. W., Divitini, M., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.229 · Cited by 47
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
